The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of BMI on outcomes of patients with metastatic renal cell carcinoma treated with targeted therapy: An external validation data set and analysis of underlying biology from The Cancer Genome Atlas.
 
Laurence Albiges
Consulting or Advisory Role - Amgen; Novartis; Pfizer; Sanofi
Speakers' Bureau - Novartis; Pfizer
Research Funding - novartis; pfizer
Travel, Accommodations, Expenses - Amgen; Novartis
 
A. Ari Hakimi
No Relationships to Disclose
 
Xun Lin
Employment - Pfizer
Leadership - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Ronit Simantov
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Emily C. Zabor
No Relationships to Disclose
 
Anders Jacobsen
No Relationships to Disclose
 
Helena Furberg
No Relationships to Disclose
 
Andre Poisl Fay
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Bayer; Novartis; Pfizer
 
Sabina Signoretti
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Verastem
 
Rana R. McKay
Research Funding - Bayer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Prostate Cancer Foundation
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer